Veon is well positioned in 5 high growth frontier markets. The company providing digital services has added another growth ...

Effective immediately, Chad Silver, Vector's President and a 16-year veteran of the company, has been appointed Chief Executive Officer. Silver's extensive experience and deep knowledge of Vector's ...

It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal ...

A recent report warns that if Canadian businesses don't accelerate generative AI adoption, they risk falling behind. Will the ...

“We’ve realized good growth in our business working with Airbyte on data movement projects and see even greater opportunities ...

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Luggage storage as a vector for piling into convenience-based revenue opportunities in the business of global travel ...

Q3 2024 Earnings Call Transcript November 7, 2024 The Trade Desk, Inc. beats earnings expectations. Reported EPS is $0.41, ...

CAPTHCA, the specialist security verification platform, has partnered with web development agency Indie Ridge to protect its ...

Her leadership in combating vector-borne diseases, along with her strategic insights ... am honored to join Eyam's Board of Advisors at such an exciting time in the company's growth. Eyam's innovative ...

Today, Silverfort, the leading identity security company, announced the acquisition of Rezonate, an innovator in ...

AAV is the top vector choice for use in gene therapies for its stable expression, strong biosafety rating, low immunogenicity, convenient ocular delivery routes and high product stability. Dr. Lu will ...